Primary Site >> Liver Cancer
Gene >> MVD
| 1. | |||||||||||
| Journal: | World J Gastroenterol. 2004 May 15;10(10):1409-14. | ||||||||||
| Title: | Effects of endostatin-vascular endothelial growth inhibitor chimeric recombinant adenoviruses on antiangiogenesis. | ||||||||||
| Author: | Pan, Xin|Wang, Yong|Zhang, Min|Pan, Wei|Qi, Zhong-Tian|Cao, Guang-Wen | ||||||||||
| PMID: | 15133844 | ||||||||||
| 2. | |||||||||||
| Journal: | J Cancer Res Clin Oncol. 2004 Sep;130(9):497-513. | ||||||||||
| Title: | Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature. | ||||||||||
| Author: | Qin, Lun-Xiu|Tang, Zhao-You | ||||||||||
| PMID: | 15205947 | ||||||||||
| 3. | |||||||||||
| Journal: | PLoS One. 2014 Jan 21;9(1):e85840. | ||||||||||
| Title: | Embryonic morphogen nodal is associated with progression and poor prognosis of hepatocellular carcinoma. | ||||||||||
| Author: | Chen, Jing|Liu, Wen-Bin|Jia, Wei-Dong|Xu, Ge-Liang|Ma, Jin-Liang|Ren, Yun|Chen, Hao|Sun, Si-Nan|Huang, Mei|Li, Jian-Sheng | ||||||||||
| PMID: | 24465741 | ||||||||||
| 4. | |||||||||||
| Journal: | PLoS One. 2014 Feb 13;9(2):e88913. | ||||||||||
| Title: | HIF-1alpha and HIF-2alpha: siblings in promoting angiogenesis of residual hepatocellular carcinoma after high-intensity focused ultrasound ablation. | ||||||||||
| Author: | Wu, Lun|Fu, Zhihao|Zhou, Shiji|Gong, Jianping|Liu, Chang An|Qiao, Zhengrong|Li, Shengwei | ||||||||||
| PMID: | 24551189 | ||||||||||
| 5. | |||||||||||
| Journal: | Onco Targets Ther. 2016 Jul 21;9:4465-71. | ||||||||||
| Title: | Mast cells positive to tryptase, endothelial cells positive to protease-activated receptor-2, and microvascular density correlate among themselves in hepatocellular carcinoma patients who have undergone surgery. | ||||||||||
| Author: | Ammendola, Michele|Sacco, Rosario|Sammarco, Giuseppe|Piardi, Tullio|Zuccala, Valeria|Patruno, Rosa|Zullo, Alessandra|Zizzo, Nicola|Nardo, Bruno|Marech, Ilaria|Crovace, Alberto|Gadaleta, Cosmo Damiano|Pessaux, Patrick|Ranieri, Girolamo | ||||||||||
| PMID: | 27499640 | ||||||||||
| 6. | |||||||||||
| Journal: | Zhonghua Gan Zang Bing Za Zhi. 2016 Sep 20;24(9):681-686. | ||||||||||
| Title: | [Inhibitory effect of migration-inducing gene-7-shRNA recombinant retrovirus combined with endostatin on growth and metastasis of hepatoma xenograft]. | ||||||||||
| Author: | Qu, B|Chen, G N|Sheng, G N|Yu, F|Lyu, Q|Gu, Y J|Guo, L|Lyu, Y | ||||||||||
| PMID: | 27788725 | ||||||||||
| 7. | |||||||||||
| Journal: | Clinics (Sao Paulo). 2016 Nov 1;71(11):639-643. | ||||||||||
| Title: | Immunohistochemical angiogenic biomarkers in hepatocellular carcinoma and cirrhosis: correlation with pathological features. | ||||||||||
| Author: | Ribeiro, Osmar Damasceno|Canedo, Nathalie Henriques Silva|Pannain, Vera Lucia | ||||||||||
| PMID: | 27982164 | ||||||||||
| 8. | |||||||||||
| Journal: | Toxicol Appl Pharmacol. 2017 Jan 15;315:90-101. | ||||||||||
| Title: | Ilexgenin A exerts anti-inflammation and anti-angiogenesis effects through inhibition of STAT3 and PI3K pathways and exhibits synergistic effects with Sorafenib on hepatoma growth. | ||||||||||
| Author: | Yang, Hao|Wang, Juan|Fan, Jin-Hong|Zhang, Ya-Qi|Zhao, Jun-Xian|Dai, Xiao-Jun|Liu, Qi|Shen, Yan-Jun|Liu, Chang|Sun, Wei-Dong|Sun, Yun | ||||||||||
| PMID: | 27986624 | ||||||||||
| 9. | |||||||||||
| Journal: | Tumori. 2017 May 12;103(3):286-291. | ||||||||||
| Title: | Advantage of sorafenib combined with radiofrequency ablation for treatment of hepatocellular carcinoma. | ||||||||||
| Author: | Tang, Zhe|Kang, Muxing|Zhang, Bo|Chen, Jianke|Fang, Heqing|Ye, Qin|Jiang, Biao|Wu, Yulian | ||||||||||
| PMID: | 28058713 | ||||||||||
| 10. | |||||||||||
| Journal: | Toxicol Appl Pharmacol. 2017 Jul 15;327:1-12. | ||||||||||
| Title: | In vivo inhibitory activity of andrographolide derivative ADN-9 against liver cancer and its mechanisms involved in inhibition of tumor angiogenesis. | ||||||||||
| Author: | Yang, Wei|Zhao, Jin|Wang, Yake|Xu, Haiwei|Wu, Zhenwei|Hu, Yangyang|Jiang, Kunkun|Shen, Pengpeng|Ma, Cuiyun|Guan, Zhenzhen|Zhang, Yan|Ma, Jiahui|Shang, Ning|Yan, Guangming|Wang, Zhenji|Dai, Guifu | ||||||||||
| PMID: | 28438631 | ||||||||||
| 11. | |||||||||||
| Journal: | Med Sci Monit. 2017 Jun 5;23:2736-2744. | ||||||||||
| Title: | High Expression of Retinoblastoma-Binding Protein 2 (RBP2) in Patients with Hepatocellular Carcinoma and Its Prognostic Significance. | ||||||||||
| Author: | Wang, Zhen-Yu|Yang, Jie|Liu, Chang-Kuo|Shen, Shi-Qiang | ||||||||||
| PMID: | 28582381 | ||||||||||
| 12. | |||||||||||
| Journal: | Neoplasma. 2017;64(5):718-724. | ||||||||||
| Title: | Sorafenib inhibits growth of hepatoma with hypoxia and hypoxia-driven angiogenesis in nude mice. | ||||||||||
| Author: | Li, F|Wang, F|Wu, J | ||||||||||
| PMID: | 28592123 | ||||||||||
| 13. | |||||||||||
| Journal: | Med Sci Monit. 2017 Oct 5;23:4779-4788. | ||||||||||
| Title: | Ubiquitin Associated Protein 2-Like (UBAP2L) Overexpression in Patients with Hepatocellular Carcinoma and its Clinical Significance. | ||||||||||
| Author: | Wang, Wei|Zhang, Min|Peng, Yan|He, Jie | ||||||||||
| PMID: | 28981479 | ||||||||||